Proprotein convertase subtilisin/kexin type 9 (PCSK9), mainly synthesized by hepatocytes and one of the key enzymes in lipid transport, was correlated with an expanded risk for hypercholesterolemia and coronary artery disease (1). This evidence concerns the gene PCSK9 and coronary artery disorder.